Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Inmune Bio (INMB) Shares Outstanding (2017 - 2025)

Inmune Bio (INMB) has disclosed Shares Outstanding for 9 consecutive years, with $26.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 19.32% to $26.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.6 million through Dec 2025, up 19.32% year-over-year, with the annual reading at $26.6 million for FY2025, 19.32% up from the prior year.
  • Shares Outstanding hit $26.6 million in Q4 2025 for Inmune Bio, roughly flat from $26.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $26.6 million in Q2 2025 to a low of $14.9 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $19.7 million across 5 years, with a median of $17.9 million in 2022.
  • Biggest five-year swings in Shares Outstanding: soared 38.95% in 2021 and later changed 0.0% in 2023.
  • Year by year, Shares Outstanding stood at $17.8 million in 2021, then grew by 0.58% to $17.9 million in 2022, then rose by 0.03% to $18.0 million in 2023, then increased by 24.12% to $22.3 million in 2024, then grew by 19.32% to $26.6 million in 2025.
  • Business Quant data shows Shares Outstanding for INMB at $26.6 million in Q4 2025, $26.6 million in Q3 2025, and $26.6 million in Q2 2025.